1. Home
  2. AGYS vs ADMA Comparison

AGYS vs ADMA Comparison

Compare AGYS & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agilysys Inc.

AGYS

Agilysys Inc.

HOLD

Current Price

$102.58

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$8.75

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGYS
ADMA
Founded
1963
2004
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.9B
IPO Year
1994
2012

Fundamental Metrics

Financial Performance
Metric
AGYS
ADMA
Price
$102.58
$8.75
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
$111.67
$25.67
AVG Volume (30 Days)
338.6K
3.3M
Earning Date
05-18-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
67.07
N/A
EPS
1.37
0.19
Revenue
$319,312,000.00
$42,219,783.00
Revenue This Year
$17.65
$27.46
Revenue Next Year
$14.36
$22.11
P/E Ratio
$71.18
$45.89
Revenue Growth
15.85
43.85
52 Week Low
$61.50
$7.21
52 Week High
$144.82
$20.46

Technical Indicators

Market Signals
Indicator
AGYS
ADMA
Relative Strength Index (RSI) 73.50 52.30
Support Level $98.00 $7.38
Resistance Level $130.58 $8.90
Average True Range (ATR) 4.57 0.33
MACD 0.39 0.12
Stochastic Oscillator 86.84 67.24

Price Performance

Historical Comparison
AGYS
ADMA

About AGYS Agilysys Inc.

Agilysys Inc provides hospitality software delivering cloud-native SaaS and on-premise solutions for hotels, resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It derives maximum revenue from the provision of software subscription and maintenance services, followed by the provision of professional services, and the sale of products (proprietary software licenses, third-party hardware, and operating systems). Agilysys operates across North America, Europe, the Middle East, Asia-Pacific, and India.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: